RoboInd market brief: Digital Twins In Healthcare Market is estimated at USD 3.68 billion in 2026. The report cites a CAGR of 30.86% over 2026–2031. By application, drug discovery & pre-clinical modelling accounted for 26.58% share of the digital twins in healthcare…
Market snapshot
- USD 3.68 billion in 2026
- USD 14.12 billion in 2031
Stated compound annual growth rate: 30.86% (2026–2031).
Key market signals
- By component, software platforms captured 55.02% of digital twins in healthcare market share in 2025, whereas patient digital twin analytics is projected to accelerate at a 35.2% CAGR through 2031.
- By application, drug discovery & pre-clinical modelling accounted for 26.58% share of the digital twins in healthcare market size in 2025, while personalized treatment optimisation is forecast to expand at a 37.23% CAGR to 2031.
- By end user, hospitals & clinics led with 60.56% share in 2025; pharmaceutical & biotech companies show the fastest growth at 32.82% CAGR through 2031.
- By geography, North America dominated with 43.42% share in 2025, but Asia-Pacific is advancing at an identical 38.28% CAGR between 2026-2031.
Market drivers and constraints
- Escalating R&D and Venture Funding for Precision-Medicine Twins
- Advanced AI/ML Integration Elevating Model Fidelity
- Adoption of Twins to Compress Drug-Discovery Timelines
- Hospital Demand for Workflow & Capacity Optimisation
- Regulatory Pilots Approving Synthetic Control Arms
- Multi-Omics Data Unlocking Rare-Disease Patient Twins
- High Implementation Cost & Complex Data Management
- Stringent Privacy & Cyber-Security Requirements
Reading the figures: Values follow the market definition and forecast period stated in the source report. Estimates using different scopes should not be combined without normalization.